KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

AbCellera Biologics (ABCL) Depreciation & Amortization - Total: 2022-2023

Historic Depreciation & Amortization - Total for AbCellera Biologics (ABCL) over the last 2 years, with Dec 2023 value amounting to $3.9 million.

  • AbCellera Biologics' Depreciation & Amortization - Total rose 39.89% to $3.9 million in Q4 2023 from the same period last year, while for Dec 2023 it was $12.9 million, marking a year-over-year increase of 43.52%. This contributed to the annual value of $12.5 million for FY2024, which is 2.05% down from last year.
  • AbCellera Biologics' Depreciation & Amortization - Total amounted to $3.9 million in Q4 2023, which was up 25.81% from $3.1 million recorded in Q3 2023.
  • Over the past 5 years, AbCellera Biologics' Depreciation & Amortization - Total peaked at $3.9 million during Q4 2023, and registered a low of $1.4 million during Q1 2022.
  • Over the past 2 years, AbCellera Biologics' median Depreciation & Amortization - Total value was $2.8 million (recorded in 2022), while the average stood at $2.7 million.
  • Data for AbCellera Biologics' Depreciation & Amortization - Total shows a peak YoY spiked of 107.14% (in 2023) over the last 5 years.
  • AbCellera Biologics' Depreciation & Amortization - Total (Quarterly) stood at $2.8 million in 2022, then spiked by 39.89% to $3.9 million in 2023.
  • Its Depreciation & Amortization - Total was $3.9 million in Q4 2023, compared to $3.1 million in Q3 2023 and $3.0 million in Q2 2023.